Pharm'Up
Researchers at VIB, VUB, and KU Leuven have uncovered a microscopic binding site within the TRPM3 ion...
Pharma News
AstraZeneca has announced breakthrough results from its Phase III MIRANDA trial, demonstrating that its experimental biologic, tozorakimab,...
Piramal Critical Care (PCC) has officially finalized its acquisition of the Kenalog® product line, a move that...
Bridging the gap between academic research and professional practice, the Department of Pharmacy Practice at SIMATS College...
Amgen has announced a major clinical breakthrough with positive topline results from its Phase 3 trial of...
The U.S. Food and Drug Administration has officially approved the first generic equivalents of Farxiga (dapagliflozin) tablets,...
The Drugs Consultative Committee (DCC) has taken a landmark step toward slashing bureaucratic red tape for India’s...
The landscape for treating Hepatocellular Carcinoma (HCC) has shifted significantly following positive high-level results from the EMERALD-3...
For years, clinical breakthroughs in diabetic kidney disease (DKD) have largely focused on Type 2 diabetes. On...
In a landmark decision for rare disease treatment, the FDA approved Kresladi (marnetegragene autotemcel) on March 27,...
